Login to Your Account



Surviving 2008: Lay-Offs, Scale-Backs, Creative Financings

By Karen Pihl-Carey


Monday, December 29, 2008
Amid the economic carnage of 2008, the biotech industry stands as a survivor, although with roughly 5,000 jobs lost, a number of shelved programs and no promises of an easier time for financings in the new year, the victory is melancholy at best.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription